Strengthens Position in India’s Fast-Growing MedTech Sector
Mumbai: Fischer Medical Ventures Limited(FISCHER | 524743 | INE771F01041),one of the leading companies engaged in the processing, manufacturing, and trading of laboratory-grade chemicals, has announced its audited financial results for FY26.
Key Consolidated Financial Highlights
|
Particulars (₹ Cr) |
FY26 |
FY25 |
YoY |
H1 FY26 |
H1 FY25 |
YoY |
|
Revenue |
30,857.56 |
11,069.87 |
179% |
19,882.56 |
6092.27 |
226% |
|
Total Income |
32,088.93 |
11,219.07 |
186% |
20,119.15 |
6144.945 |
227% |
|
EBITDA |
5,539.71 |
480.88 |
1052% |
2,493.40 |
352.605 |
607% |
|
EBITDA margin |
17.3% |
4.3% |
1300 BPS |
12.4% |
5.7% |
670 BPS |
|
Net Profit |
3,107.38 |
120.02 |
2489% |
1,210.64 |
101.04 |
1098% |
|
Net Profit % |
9.7% |
1.1% |
860 BPS |
6.0% |
1.6% |
440 BPS |
|
EPS (Diluted) |
0.45 |
0.02 |
2144% |
0.17 |
0.011 |
1433% |
|
Commenting on the Results, Mr. Ravindran Govindan, Chairman of Fischer Medical Ventures Limited, said: “FY26 was a very strong year for Fischer, marking significant improvement across all operational and financial parameters. The steep rise in profitability reflects the scalability of our model, better product realization, and the growing acceptance of Fischer’s technology across India and overseas markets.
India’s MedTech and diagnostic industry is expanding rapidly, driven by government focus on indigenous manufacturing, preventive care, and AI-led healthcare solutions. Fischer is well aligned with these trends, leveraging its expertise in MRI systems, AI diagnostics, and digital health platforms to strengthen its position in this evolving landscape.
With our expanding footprint across Southeast Asia, new product launches, and advanced solutions such, we are confident of sustaining this growth momentum and creating long-term value for all” |
Key Business Highlights for FY26
|
Launch of new X- Ray Projects in India and Indonesia |
· Partnered City of Jember to deploy AI-powered portable X-ray systems.Supports “TB Free Jember by 2026” & TB elimination by 2030 projects valued at USD 10 million (approx.) · Secured full licensing in Indonesia, eligible to participate in End-TB Handheld X-ray Government Tender · Award of order by the Tamil Nadu Animal Husbandry Department for supply and installation of 65 Digital Radiography Units. |
|
Expansion in Philippines Markets |
· Province of Bulacan inaugurated the country’s first locally funded MRI facility developed by Time Medical. |
|
Diagnostic Imaging Expansion in India |
· Launched High-Resolution Open MRI at Sunray Scans, Chennai · Installed PICA 0.35T Open MRI at STNM Hospital, Sikkim · Launch of New Low-Field TOF MRI Platform MRI, VEGA specifically for brain aneurysm. · Successful launch of next-generation 1.5T MRI platforms – MICA and QUIN – at IRIA 2026. |
|
Launch of DRIS-iMRI Medharanya |
· Development of DRIS- iMRI Medharanya, an Inter-OP MRI in partnership with Dr. Iype Cherian. · The Interop MRI is designed to revolutionize · interoperative imaging, providing surgeons withreal-time visualization during complexneurosurgical procedures. |
|
World Federation of Neurosurgical Societies (WFNS) Partnership |
· Recognised as Industry Partner of WFNS Innovation and Technological Committee. First Industry partner recognised in WFNS history. |
|
Nanomedic – Operational & Regulatory Progress |
· Completed Phase 1 MDR/MDD audit; Phase 2 due Oct 2025 · Preparing SpinCare® FDA filing; outcome expected Q2 FY27 |
